KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Palvella Therapeutics (PVLA) Change in Receivables (2017 - 2025)

Palvella Therapeutics has reported Change in Receivables over the past 3 years, most recently at $12.1 million for Q4 2017.

  • Quarterly Change in Receivables changed N/A to $12.1 million in Q4 2017 from the year-ago period, while the trailing twelve-month figure was $14.5 million through Dec 2017, changed N/A year-over-year, with the annual reading at -$387000.0 for FY2025, N/A changed from the prior year.
  • Change in Receivables was $12.1 million for Q4 2017 at Palvella Therapeutics, up from -$44.1 million in the prior quarter.
  • Over five years, Change in Receivables peaked at $46.5 million in Q2 2017 and troughed at -$44.1 million in Q3 2017.
  • The 3-year median for Change in Receivables is -$43940.5 (2014), against an average of $1.7 million.
  • The largest YoY upside for Change in Receivables was 128.06% in 2017 against a maximum downside of 128.06% in 2017.
  • A 3-year view of Change in Receivables shows it stood at -$474418.0 in 2014, then surged by 114.52% to $68870.0 in 2016, then surged by 17515.96% to $12.1 million in 2017.
  • Per Business Quant, the three most recent readings for PVLA's Change in Receivables are $12.1 million (Q4 2017), -$44.1 million (Q3 2017), and $46.5 million (Q2 2017).